Table 3.
The proportion of dwell times (total duration of follow-up at a given level) in percentages by the four IAb levels per trajectory and diagnosis for each autoantibody
| IAb, trajectory | Diagnosis | N | L0 | L1 | L2 | L3 |
|---|---|---|---|---|---|---|
| GADA | ||||||
| TR1*** | D | 256 | 71.5 | 13.9 | 9.0 | 5.6 |
| UD | 483 | 95.5 | 2.4 | 1.0 | 1.1 | |
| TR2*** | D | 273 | 53.7 | 16.1 | 18.3 | 11.9 |
| UD | 257 | 84.9 | 5.6 | 4.7 | 4.7 | |
| TR3*** | D | 114 | 43.1 | 19.9 | 21.9 | 15.1 |
| UD | 762 | 74.3 | 13.9 | 6.9 | 4.9 | |
| IAA | ||||||
| TR1 | D | 256 | 76.4 | 14.4 | 3.1 | 6 |
| UD | 483 | 86.9 | 10.9 | 1.2 | 1 | |
| TR2* | D | 273 | 45.1 | 27.3 | 8.8 | 18.9 |
| UD | 257 | 64.3 | 21 | 4.5 | 10.3 | |
| TR3 | D | 114 | 91.5 | 7.2 | 0.5 | 0.7 |
| UD | 762 | 98 | 1.8 | 0.1 | 0.1 | |
| IA-2A | ||||||
| TR1*** | D | 256 | 56.7 | 1.3 | 29.4 | 12.5 |
| UD | 483 | 93.9 | 0.4 | 4.7 | 0.9 | |
| TR2*** | D | 273 | 53.8 | 2.2 | 33.5 | 10.5 |
| UD | 257 | 91 | 0.5 | 6.9 | 1.6 | |
| TR3*** | D | 114 | 69.7 | 1.6 | 23.2 | 5.5 |
| UD | 762 | 94.3 | 0.8 | 3.9 | 1 |
D, diagnosed; UD, undiagnosed. χ2 tests show significant differences in the proportions between diagnosis within each trajectory:
*
P < 0.05;
***
P < 0.001.